However, in breast cancer patients, low CRIP1 expression could enhance cell proliferation and invasion by enhancing the mitogen-activated protein kinase phosphorylation and reducing the CDC2 phosphorylation (Ludyga et al., 2013). Here, CRIP1 is linked to breast cancer.